Invitrogen™ Human WDR35 Synthetic Peptide
WDR35 Synthetic Peptide, PEP-1413, from Invitrogen.
- Gene ID (Enter)
- 57539
- Species
- Human
- Purification method
- Purified
- Accession number
- Q9P2L0
- Common name
- Human WDR35
- Brand
- Invitrogen
WDR35 Synthetic Peptide, PEP-1413, from Invitrogen.
WDR35 Synthetic Peptide, PEP-1413, from Invitrogen.
WD40 repeats are a common structural module in eukaryotic proteins, and proteins containing WD40 domains have a wide range of functions, including signal transduction, cell cycle regulation, RNA splicing, and transcription. One such protein, WDR35, also known as CED2, has been shown to be mutated in patients with Sensenbrenner syndrome/cranioectodermal dysplasia (CED), an autosomal-recessive disease that is characterized by craniosynstosis and ectodermal and skeletal abnormalities. WDR35 localizes to cilia and dentrosomes during embryogenesis and human and mouse fibroblasts that lack this gene fail to produce cilia. Mutations in this gene can also cause short-rib polydactyly syndromes due to abnormal ciliogenesis.
Species: Human.
Storage: -20°C.
Concentration: 200 μg/mL.
Research only (RUO).
Packaging: 50 μg.
| General | |
|---|---|
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15285319 |
| Specifications | |
| Gene ID (Enter) | 57539 |
| Species | Human |
| Purification method | Purified |
| Accession number | Q9P2L0 |
| Common name | Human WDR35 |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formula | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| For use with (application) | Blocking Assay, Control |
| Gene symbol(s) | WDR35 |
| Lyophilized | No |
| Product type | Peptide |
| Quantity | 50 μg |
| Regulatory status | RUO - research use only |
| Storage and shipping | |
| Content and storage | -20°C |
| Conservative | 0.02% sodium azide |
| Storage stamp | PBS |
| Manufacturer ref. | PEP-1413 |
|---|---|
| Country of origin | United States |
| HS customs code | 3824 99 92 00 |